Malaria Breakthrough: New Drug Compounds Target Parasite Enzymes
A new class of peptidomimetic plasmepsin inhibitors shows remarkable potential in combating malaria by selectively targeting key enzymes in the parasite. Learn how these compounds could revolutionize malaria treatment.